Health July 01, 2021 Study shows CureVac vaccine is 100% effective against death from COVID Phase 3 study results have shown that the German CureVac vaccine is 100% effective at preventing hospitalization or death from any variant of the COVID-19 virus.
Research June 10, 2021 CureVac vaccine protocol: public-private collaboration success story Clinical trials for the CureVac vaccine carried out by private institutions such as TecSalud and the Mexican government have made public-private synergy necessary.
Education June 01, 2021 Tec students’ social project wins international award Proyecto 99, a social project working to prevent school dropouts through activities and support provided by Tec students, wins the Universitas 21 consortium’s RISE awards.
Education May 27, 2021 Better spaces: Tec and UIC designing the home office The Tec’s School of Architecture, Art, and Design is working on a transnational design project with the University of Illinois at Chicago and companies VERSA and Interior Innovation.
Entrepreneurs May 18, 2021 Project by Mexicans named best business model by UNESCO Parthenon Academy, a digital platform giving access to basic education, has been developed by PrepaTec students and young people from different universities around the world.
Institution May 05, 2021 Global rankings highlight Tec as university with social impact THE Impact Rankings 2021 highlight Tec de Monterrey as a world-leading university for social impact.
Health May 03, 2021 Mexican CureVac vaccine studies move ahead with TecSalud TecSalud demonstrates research leadership by participating in the German CureVac COVID-19 vaccine clinical trial.
Health February 17, 2021 TecSalud begins Phase 3 trials of German CureVac vaccine in Mexico TecSalud has started administering the vaccine candidate from German pharmaceutical company CureVac for its Phase 3 clinical trials.
Health January 11, 2021 TecSalud to begin testing German vaccine against COVID-19 in Mexico TecSalud, Tec de Monterrey’s health system, has announced that it will begin a phase 3 trial of the German CureVac vaccine against COVID-19.
Education December 16, 2020 Learning and skills for the future! 5 projects win the TPrize The TPrize final, an open innovation initiative from Tec de Monterrey and University of Los Andes, was held virtually at the Tec’s 7th International Conference on Educational Innovation, where 5 projects were named winners.
